Cambridge Financial Group Inc. Has $4.75 Million Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Cambridge Financial Group Inc. cut its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 1.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 181,768 shares of the pharmacy operator’s stock after selling 2,806 shares during the quarter. Walgreens Boots Alliance accounts for 2.4% of Cambridge Financial Group Inc.’s portfolio, making the stock its 29th largest position. Cambridge Financial Group Inc.’s holdings in Walgreens Boots Alliance were worth $4,746,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also made changes to their positions in the company. National Bank of Canada FI grew its holdings in shares of Walgreens Boots Alliance by 56.7% during the fourth quarter. National Bank of Canada FI now owns 1,190,975 shares of the pharmacy operator’s stock valued at $31,728,000 after buying an additional 430,760 shares in the last quarter. Axxcess Wealth Management LLC purchased a new position in Walgreens Boots Alliance during the 4th quarter valued at about $261,000. U.S. Capital Wealth Advisors LLC purchased a new position in Walgreens Boots Alliance during the 4th quarter valued at about $206,000. Los Angeles Capital Management LLC purchased a new stake in shares of Walgreens Boots Alliance in the fourth quarter worth approximately $7,389,000. Finally, Natixis Advisors L.P. boosted its holdings in shares of Walgreens Boots Alliance by 34.3% during the fourth quarter. Natixis Advisors L.P. now owns 248,154 shares of the pharmacy operator’s stock worth $6,479,000 after purchasing an additional 63,432 shares during the period. 58.59% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director Inderpal S. Bhandari acquired 3,000 shares of the firm’s stock in a transaction dated Thursday, April 11th. The shares were bought at an average price of $18.05 per share, with a total value of $54,150.00. Following the acquisition, the director now owns 3,000 shares of the company’s stock, valued at $54,150. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Walgreens Boots Alliance news, CFO Manmohan Mahajan purchased 6,000 shares of the business’s stock in a transaction on Tuesday, April 2nd. The stock was purchased at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the purchase, the chief financial officer now directly owns 166,969 shares in the company, valued at $3,235,859.22. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Inderpal S. Bhandari acquired 3,000 shares of the stock in a transaction dated Thursday, April 11th. The stock was bought at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the purchase, the director now owns 3,000 shares in the company, valued at approximately $54,150. The disclosure for this purchase can be found here. 17.40% of the stock is owned by company insiders.

Analysts Set New Price Targets

WBA has been the topic of several research analyst reports. UBS Group lowered their price target on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a report on Wednesday, April 3rd. HSBC reaffirmed a “reduce” rating and set a $20.00 price target (down from $27.00) on shares of Walgreens Boots Alliance in a research note on Tuesday, February 20th. Truist Financial reissued a “hold” rating and issued a $25.00 price target on shares of Walgreens Boots Alliance in a research note on Monday, April 1st. Raymond James reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Tuesday, March 26th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a research report on Wednesday, April 3rd. Four equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, Walgreens Boots Alliance presently has a consensus rating of “Hold” and a consensus price target of $24.36.

Walgreens Boots Alliance Stock Performance

NASDAQ:WBA traded up $0.28 during mid-day trading on Friday, hitting $17.81. 7,528,623 shares of the company’s stock traded hands, compared to its average volume of 10,049,602. The firm has a market capitalization of $15.36 billion, a price-to-earnings ratio of -2.54, a price-to-earnings-growth ratio of 1.10 and a beta of 0.80. The firm has a 50 day moving average of $19.59 and a two-hundred day moving average of $21.58. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50. Walgreens Boots Alliance, Inc. has a 12 month low of $17.25 and a 12 month high of $32.89.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.82 by $0.38. The business had revenue of $37.05 billion for the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. Walgreens Boots Alliance’s quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter last year, the company posted $1.16 earnings per share. On average, equities analysts forecast that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st will be paid a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 5.61%. The ex-dividend date is Monday, May 20th. Walgreens Boots Alliance’s payout ratio is presently -14.29%.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.